Market Currents
Perrigo (PRGO +1.6%) receives FDA approval to market its generic testosterone gel 1%. The...
-
Tuesday, February 5, 2:29 PM ETPerrigo (PRGO +1.6%) receives FDA approval to market its generic testosterone gel 1%. The product is a generic version of AbbVie's (ABBV +0.4%) AndroGel 1%, which is indicated to treat adult males who have low or no testosterone.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
